Edition:
United Kingdom

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

5.80USD
16 Aug 2018
Change (% chg)

$0.40 (+7.41%)
Prev Close
$5.40
Open
$5.45
Day's High
$5.82
Day's Low
$5.38
Volume
48,617
Avg. Vol
57,939
52-wk High
$13.15
52-wk Low
$5.35

Chart for

About

Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to... (more)

Overall

Beta: --
Market Cap(Mil.): $255.53
Shares Outstanding(Mil.): 28.08
Dividend: --
Yield (%): --

Financials

  NEOS.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -4.45 -- --
ROI: -84.78 15.07 14.61
ROE: -242.19 16.59 16.33

BRIEF-Neos Therapeutics Reiterates Confidence In Strategic Plan And Value Creation Opportunities

* NEOS THERAPEUTICS REITERATES CONFIDENCE IN STRATEGIC PLAN AND VALUE CREATION OPPORTUNITIES

20 Feb 2018

Competitors

  Price Chg
Eli Lilly And Co (LLY.N) $104.36 +1.03
Pfizer Inc. (PFE.N) $41.42 +0.26
Concordia International Corp (CXR.TO) $0.24 +0.03
Novartis AG (NOVN.S) CHF82.20 +0.48
Shire PLC (SHP.L) 4,443.00 --
Shire PLC (3159084.L) -- --

Earnings vs. Estimates